Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced that ten abstracts have been accepted for presentation at ...

Chagee Holdings Limited (NASDAQ: CHA) ('Chagee” or the 'Company”), a leading premium tea drinks brand serving healthy and delicious freshly-made tea drinks, today announced its unaudited financial ...

UP Fintech Holding Limited (NASDAQ: TIGR) ('UP Fintech” or the 'Company”), a leading online brokerage firm focusing on global investors, today announced its unaudited financial results for the first ...

Eli Lilly and Company today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), retatrutide, eloralintide and bimagrumab will be presented at ...

Symeou Dental Center, a well-established dental clinic based in the heart of Nicosia, has announced the expansion of its ...

Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced that Dr. Shantanu Gaur, Founder and Chief Executive Officer, ...

MODY 5 is a rare genetic diabetes subtype caused by HNF1B mutations or deletions, often presenting with early-onset diabetes and kidney, liver, or pancreatic abnormalities. Accurate genetic diagnosis ...

In a moment of prestige and international recognition, Dr Shabir Hassan, a leading Kashmir biotechnology researcher and academic from Khalifa University in the United Arab Emirates, was awarded the ...

According to Future Market Insights, myelofibrosis (mf) treatment market is expected to grow at a CAGR of 5.5% between 2023 and 2033, reaching USD 1,280 Million by 2033. The market is expected to ...

H5 avian flu vaccine study shows positive interim results Company has been notified that HHS will terminate Moderna’s award ...

"I, like many other advisers, spent many hours after school and on weekends, while students worked on their events," Mitchell's Joan Anderson writes in a column about FCCLA.

NanoViricides, Inc. (NYSE American: NNVC) announced it will present at the BIO International Convention 2025 in Boston on Monday, June 16 at 2:30 p.m ...